Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
University Of Minnesota scientists describe breakthrough in research related to FSHD

University Of Minnesota scientists describe breakthrough in research related to FSHD

Penn researchers find abnormally shortened telomeres in young DMD patients’ muscle stem cells

Penn researchers find abnormally shortened telomeres in young DMD patients’ muscle stem cells

Cardiac stem cells from young hearts can make older hearts young, study says

Cardiac stem cells from young hearts can make older hearts young, study says

Cardiac stem cell infusions could help reverse aging process in the heart, study shows

Cardiac stem cell infusions could help reverse aging process in the heart, study shows

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Preclinical study demonstrates efficacy of gene therapy in treatment of Duchenne muscular dystrophy

Preclinical study demonstrates efficacy of gene therapy in treatment of Duchenne muscular dystrophy

Cellular antennae play key role in muscle-to-fat transformation

Cellular antennae play key role in muscle-to-fat transformation

Weekly doses of steroids help hasten recovery in muscle injuries

Weekly doses of steroids help hasten recovery in muscle injuries

Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD

Preclinical data reinforces potential efficacy, durability of investigational gene therapy for DMD

Actress Kiruna Stamell argues about gene editing with Dr Christopher Gyngell

Actress Kiruna Stamell argues about gene editing with Dr Christopher Gyngell

Researchers correct Duchenne muscular dystrophy using gene-editing alternative

Researchers correct Duchenne muscular dystrophy using gene-editing alternative

Early treatment with heart failure drug can improve cardiac function in young boys with DMD

Early treatment with heart failure drug can improve cardiac function in young boys with DMD

FDA approves new treatment for wide range of patients with Duchenne muscular dystrophy

FDA approves new treatment for wide range of patients with Duchenne muscular dystrophy

Researchers find striking differences between countries, age groups in access to proper care for DMD

Researchers find striking differences between countries, age groups in access to proper care for DMD

MDA celebrates FDA approval of new spinal muscular atrophy drug

MDA celebrates FDA approval of new spinal muscular atrophy drug

Cedars-Sinai receives $7.3 million grant to test safety of novel cell-based therapy in treating PAH

Cedars-Sinai receives $7.3 million grant to test safety of novel cell-based therapy in treating PAH

New drug treatment can override genetic fault that causes choroideremia

New drug treatment can override genetic fault that causes choroideremia

FDA approval of controversial drug for Duchenne muscular dystrophy raises concern and hope

FDA approval of controversial drug for Duchenne muscular dystrophy raises concern and hope

Fight for Sight, Thomas Pocklington collaborate to fund new neuro-ophthalmology research

Fight for Sight, Thomas Pocklington collaborate to fund new neuro-ophthalmology research

Immune system plays important role in Duchenne muscular dystrophy, research reveals

Immune system plays important role in Duchenne muscular dystrophy, research reveals